In conclusion, by utilizing mouse models of a broad array of aggressive cancers and by performing a pan-cancer analysis, we have identified biomarkers associated with cancer progression: two TAp63-regulated oncogenic lncRNAs or TROLLs and one of their common interacting proteins, WDR26. Here, WDR26 is linked to cancer.